Sign In
Buy AMGN
$338.22
+9.96 (+3.03%)
At Close: Jun 03, 2026
Undercovered Dozen: Christian Dior, Coca-Cola, Trinity Capital, Amgen And More
01:51pm, Friday, 18'th Jul 2025
This week's Undercovered Dozen spotlights 12 lesser-known stocks with compelling investment theses, spanning micro-nuclear, luxury, biotech, and high-yield BDCs. Highlighted opportunities include NANO
Can Amgen (AMGN) Keep the Earnings Surprise Streak Alive?
01:11pm, Thursday, 17'th Jul 2025
Amgen (AMGN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
09:51am, Thursday, 17'th Jul 2025
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
Amgen: Biosimilars And Rare Disease Pipeline Crucial To Overcome Patent Cliff Concerns
11:40pm, Tuesday, 15'th Jul 2025
Key acquisitions since 2022 increased Amgen's rare disease pipeline and footprint in the market, with the company poised to benefit from the rare disease market's 10.35% CAGR up to 2037. A growing por
What Makes Amgen (AMGN) a New Buy Stock
01:01pm, Tuesday, 15'th Jul 2025
Amgen (AMGN) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Are Medical Stocks Lagging Amgen (AMGN) This Year?
10:41am, Tuesday, 15'th Jul 2025
Here is how Amgen (AMGN) and Aldeyra Therapeutics, Inc. (ALDX) have performed compared to their sector so far this year.
Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It
10:00am, Tuesday, 15'th Jul 2025
Amgen (AMGN) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Amgen: Great Starting Yield For This Wealth Compounder
08:00am, Tuesday, 15'th Jul 2025
Amgen offers an economic moat with patent protection, a robust pipeline, and strong execution, making it a defensive long-term investment. Double-digit sales growth in key drugs and a burgeoning biosi
Amgen (AMGN) is a Top-Ranked Growth Stock: Should You Buy?
10:46am, Monday, 14'th Jul 2025
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Amgen (AMGN) Falls More Steeply Than Broader Market: What Investors Need to Know
06:51pm, Friday, 11'th Jul 2025
In the latest trading session, Amgen (AMGN) closed at $295.18, marking a -1.73% move from the previous day.
1 Top Dividend Growth Stock to Buy Right Now
04:21am, Thursday, 10'th Jul 2025
Generating passive income is great for investors, and holding dividend-paying stocks is an excellent way to do that. However, not all corporations that pay dividends will be attractive to income seeke
Amgen: A Defensive Biotech With Yield And Optionality
05:29pm, Wednesday, 09'th Jul 2025
Amgen has transitioned into a mature, cash-generating pharma-biotech hybrid, offering defensive characteristics, capital preservation, and yield over high-growth potential. The diversified product bas
Amgen (AMGN) Advances While Market Declines: Some Information for Investors
07:01pm, Tuesday, 08'th Jul 2025
Amgen (AMGN) closed the most recent trading day at $297, moving +1.38% from the previous trading session.
Amgen (AMGN) Outperforms Broader Market: What You Need to Know
06:50pm, Wednesday, 02'nd Jul 2025
The latest trading day saw Amgen (AMGN) settling at $296.85, representing a +2.18% change from its previous close.
Final Trades: Amgen, Caterpillar, Honeywell and Freeport-McMoran
01:22pm, Wednesday, 02'nd Jul 2025
The Investment Committee give you their top stocks to watch for the second half.
